Andrew Einhorn
Directeur Financier/CFO chez RELIEF THERAPEUTICS HOLDING SA
Profil
Mr. Andrew J.
Einhorn, CPA, is a Chief Financial Officer at RELIEF THERAPEUTICS Holding SA, a Chief Financial Officer at Osmotica Pharmaceutical Corp.
and a Venture Advisor at Israel Biotech Fund.
Mr. Einhorn was previously employed as a Chief Accounting Officer by Cognition Therapeutics, Inc., a Chief Financial & Accounting Officer by RVL Pharmaceuticals Plc, a Chief Financial Officer by Edge Therapeutics, Inc., a Chief Financial Officer by MYOS Corp., a Chief Financial Officer & Executive VP by Oceana Therapeutics, Inc., a Chief Financial Officer & Executive Vice President by Esprit Pharma, Inc., a Chief Financial Officer & Senior Vice President by ESP Pharma, Inc., a Managing Director by Credit Lyonnais, a Vice President by BT Securities Co., Ltd., a Vice President by Chase Securities, Inc., and a Managing Director by The PNC Financial Services Group, Inc. He received his undergraduate degree from American University, an undergraduate degree from Middlebury College and a graduate degree from Northwestern University.
Postes actifs de Andrew Einhorn
| Sociétés | Poste | Début |
|---|---|---|
| RELIEF THERAPEUTICS HOLDING SA | Directeur Financier/CFO | 08/05/2024 |
Israel Biotech Fund
 Israel Biotech Fund Investment ManagersFinance Israel Biotech Fund (Israel Biotech) is a venture capital firm founded in 2015 by Yuval Cabilly, David Sidransky, and Gidon Zairi. The firm is headquartered in Rehovot, Israel. | Consultant / Advisor | 01/01/2015 |
Osmotica Pharmaceutical Corp.
 Osmotica Pharmaceutical Corp. Pharmaceuticals: MajorHealth Technology Osmotica Pharmaceutical Corp. provides drug delivery technologies and neurology based therapies. It develops and commercializes a portfolio of products related to central nervous system disorders with a focus in Parkinson's disease and related neurological disorders. The company was founded in 1986 and is headquartered in Bridgewater, GA. | Directeur Financier/CFO | 01/09/2017 |
Anciens postes connus de Andrew Einhorn
| Sociétés | Poste | Fin |
|---|---|---|
| COGNITION THERAPEUTICS, INC. | Directeur Financier/CFO | 01/05/2023 |
| RVL PHARMACEUTICALS PLC | Directeur Financier/CFO | 18/04/2022 |
Edge Therapeutics, Inc.
 Edge Therapeutics, Inc. BiotechnologyHealth Technology Edge Therapeutics, Inc. is clinical-stage biotechnology company, which engages in the discovery, development, and commercialization of novel, hospital-based therapies capable of transforming treatment paradigms in the management of acute, life-threatening neurological and other conditions. Its product candidate is the EG-1962. The company was founded on January 22, 2009 by Brian A. Leuthner, Robert Loch Macdonald and Carl J. Soranno and is headquartered in Berkeley Heights, NJ. | Directeur Financier/CFO | 10/03/2017 |
| MEDAVAIL HOLDINGS, INC. | Directeur Financier/CFO | 06/02/2013 |
Oceana Therapeutics, Inc.
 Oceana Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Oceana Therapeutics, Inc. manufactures pharmaceuticals and medical devices. It develops and commercializes therapeutics with a focus on colorectal, gastroenterology, and urological diseases. The firm provides Deflux that is used for the treatment of Vesicoureteral reflux, urological conditions and Solesta which is used for the treatment of fecal incontinence. The company was founded in 2008 and is headquartered in Edison, NJ. | Fondateur | 01/01/2012 |
Formation de Andrew Einhorn
| Middlebury College | Undergraduate Degree |
| Northwestern University | Graduate Degree |
| American University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 4 |
|---|---|
| RVL PHARMACEUTICALS PLC | Health Technology |
| COGNITION THERAPEUTICS, INC. | Health Technology |
| PNC FINANCIAL SERVICES GROUP, INC. | Finance |
| RELIEF THERAPEUTICS HOLDING SA | Health Technology |
| Entreprise privées | 10 |
|---|---|
ESP Pharma, Inc.
 ESP Pharma, Inc. Pharmaceuticals: MajorHealth Technology ESP Pharma, Inc. produces pharmaceutical products. The company used to produce drug for acute-care hospital use and these drugs include therapeutics for high blood pressure and angina; one product, IV Busulfex, is used to prepare myelogenous for leukemia patients for bone marrow transplants. The company formulates its products to be delivered intravenously or by injection when oral administration is impossible. The company was founded in April, 2002 and was headquartered in Edison, NJ | Health Technology |
Esprit Pharma, Inc.
 Esprit Pharma, Inc. Pharmaceuticals: MajorHealth Technology Esprit Pharma, Inc. manufactures and supplies pharmaceutical products. The company offers SANCTURA, a treatment for over-active bladder and PRO-QUIN, a treatment for urinary tract infections. The company was founded in 2005 and is headquartered in East Brunswick, NJ. | Health Technology |
Oceana Therapeutics, Inc.
Oceana Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Oceana Therapeutics, Inc. manufactures pharmaceuticals and medical devices. It develops and commercializes therapeutics with a focus on colorectal, gastroenterology, and urological diseases. The firm provides Deflux that is used for the treatment of Vesicoureteral reflux, urological conditions and Solesta which is used for the treatment of fecal incontinence. The company was founded in 2008 and is headquartered in Edison, NJ. | Health Technology |
MYOS RENS Technology, Inc.
 MYOS RENS Technology, Inc. Medical SpecialtiesHealth Technology MYOS RENS Technology, Inc. operates as a nutrition company, develops and markets products that improve muscle health and performance. Its primary product is Fortetropin, a proprietary bioactive composition derived from fertilized egg yolk, intended to increase lean muscle mass, size, and strength. The company was founded on April 11, 2007 and is headquartered in Cedar Knolls, NJ. | Health Technology |
Edge Therapeutics, Inc.
Edge Therapeutics, Inc. BiotechnologyHealth Technology Edge Therapeutics, Inc. is clinical-stage biotechnology company, which engages in the discovery, development, and commercialization of novel, hospital-based therapies capable of transforming treatment paradigms in the management of acute, life-threatening neurological and other conditions. Its product candidate is the EG-1962. The company was founded on January 22, 2009 by Brian A. Leuthner, Robert Loch Macdonald and Carl J. Soranno and is headquartered in Berkeley Heights, NJ. | Health Technology |
Osmotica Pharmaceutical Corp.
Osmotica Pharmaceutical Corp. Pharmaceuticals: MajorHealth Technology Osmotica Pharmaceutical Corp. provides drug delivery technologies and neurology based therapies. It develops and commercializes a portfolio of products related to central nervous system disorders with a focus in Parkinson's disease and related neurological disorders. The company was founded in 1986 and is headquartered in Bridgewater, GA. | Health Technology |
Israel Biotech Fund
Israel Biotech Fund Investment ManagersFinance Israel Biotech Fund (Israel Biotech) is a venture capital firm founded in 2015 by Yuval Cabilly, David Sidransky, and Gidon Zairi. The firm is headquartered in Rehovot, Israel. | Finance |
Credit Lyonnais
 Credit Lyonnais Major BanksFinance Part of Rue la Boétie SAS, Credit Lyonnais provides commercial banking services. The company is based in Frankfurt am Main, Germany. | Finance |
| Chase Securities, Inc. | Finance |
| BT Securities Co., Ltd. | Finance |
